Press Releases Events & Presentations Press Releases Year None20202019201820172016201520142013201220112010 Jul 02, 2020 Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Jun 25, 2020 Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection View HTML PDF Version Jun 22, 2020 Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II View HTML PDF Version Jun 18, 2020 Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs View HTML PDF Version Jun 01, 2020 Assembly Biosciences Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version May 27, 2020 Assembly Biosciences Announces Management Transition View HTML PDF Version May 26, 2020 Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference View HTML PDF Version May 19, 2020 Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020 View HTML PDF Version May 07, 2020 Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results View HTML PDF Version May 04, 2020 Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements View HTML PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None20202019201820172016201520142013201220112010 Jul 02, 2020 Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Jun 25, 2020 Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection View HTML PDF Version Jun 22, 2020 Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II View HTML PDF Version Jun 18, 2020 Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs View HTML PDF Version Jun 01, 2020 Assembly Biosciences Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version May 27, 2020 Assembly Biosciences Announces Management Transition View HTML PDF Version May 26, 2020 Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference View HTML PDF Version May 19, 2020 Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020 View HTML PDF Version May 07, 2020 Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results View HTML PDF Version May 04, 2020 Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements View HTML PDF Version Pagination Current page 1 Page 2 Next page next › Last page last »
